| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo. | Nat Biotechnol | 2016 | 1.44 |
| 2 | FXR1 regulates transcription and is required for tumor growth in TP53 homozygous deletion human cancers. | Elife | 2017 | 0.75 |